Wearable health-technology company founded in 2021 and headquartered in Hong Kong that develops subscription-free smart rings for sleep, activity and everyday health monitoring. Its smart ring received FDA 510(k) clearance for non-invasive blood oxygen (SpO2) measurement in October 2026.
RingConn's smart ring has received FDA 510(k) clearance for non-invasive blood oxygen (SpO2) measurement, positioning the wearable as a cleared consumer health device for continuous oxygen tracking.